Metoprolol Succinate Extended-Release Tablets — Class II drug recall D-1355-2014
Terminated recall by Wockhardt Usa Inc., reported 2014-06-04, distributed nationwide. Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
| Recall number | D-1355-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Wockhardt Usa Inc., Parsippany, NJ, United States |
| Recall initiated | 2014-04-10 |
| Classified | 2014-05-29 |
| Reported by FDA | 2014-06-04 |
| Terminated | 2015-08-13 |
| Distributed | Nationwide (US) |
| Quantity | 8,712 bottles |
| Reason classes | specification failure |
| NDC | 64679-0736-02 |
| Lot numbers | LN11423 |
| Expiration dates | 2015-08-15 |
Product
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02.
Reason for recall
Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1355-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.